SUBTENON STEROID INJECTION WITH MACULAR PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA

Authors' Reports

Chung-May Yang
describes for SIIC the most significant aspects of his article
describe para SIIC los aspectos relevantes de su artículo

SUBTENON STEROID INJECTION WITH MACULAR PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA

One or two sessions of sequential posterior subtenon injection of triamcinolone acetonide combined with macular focal/grid photocoagulation may improve or stabilize visual acuity, macular thickness and total macular volume for at least six months in patients with clinical significant macular edema (CSME).

The article was published by
El artículo fue publicado por

Taiwan Journal of Ophthalmology
Volume / Volumen: 2
Number / Número: 4
First and last pages / Páginas inicial-final: 131-135
Year / Año: 2012
Month / Mes: december

Principal institution where the research took place
Institución principal de la investigación
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan, Taiwan

Authors' Report
Crónica del Autor
Print

Bibliographic references
Referencias bibliográficas

Akduman L, Olk RJ. Laser photocoagulation of diabetic macular edema. Ophthalmic Surg Lasers 28:387-408, 1997.
Arevalo JF, Sanchez JG, Wu L, Maia M, Alezzandrini AA, Brito M, et al. Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Ophthalmology 116:1488-97, 2009.
Bakri SJ, Kaiser PK. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol 139:290-4, 2005.
Choi YJ, Oh IK, Oh JR, Huh K. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. Korean J Ophthalmol 20:205-9, 2006.
Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999-1005, 2006.
Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 120:55-64, 1995.
Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 121:729-30, 2003.
Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61, 2003.
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-7, 2002.
Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111:218-24, 2004.
Moshfeghi DM, Kaiser PK, Scott IU. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791-6, 2003.
Moss SE, Klein R, Klein BE. The incidence of visual loss in diabetic population. Ophthalmology 95:1340-8, 1988.
Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J, et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 142:961-9, 2006. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, et al. READ-2 Study Group. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology 117:2146-51, 2010.
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 103:1796-806, 1985.
Shimura M, Nakazawa T, Yasuda K, Shiono T, Nishida K. Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema. Br J Ophthalmol 91:449-54, 2007.
Shimura M, Yasuda K, Shiono T. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Ophthalmology 113:381-7, 2006.
Tunc M, Onder HI, Kaya M. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology 112:1086-91, 2005.
Verma LK, Vivek MB, Kumar A, Tewari HK, Venkatesh P. A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema. J Ocul Pharmacol Ther 20:277-84, 2004.

SIIC System of Assisted Editing (SSEA)
/ Sistema SIIC de Edición Asistida (SSEA)



The authors' report was accepted on La crónica del autor fue aprobada el 2021, march 9	Published in siicsalud Publicado en siicsalud 2021, june 7

The article is strictly related to the following sections of siicsalud
El artículo se relaciona estrictamente con las siguientes secciones de siicsalud

Diabetology
/ Diabetología

Ophthalmology
/ Oftalmología

and secondarily related to the following sections
y secundariamente con las siguientes secciones

Endocrinology and Metabolism
Endocrinología y Metabolismo

Pharmacology
Farmacología

Ophtalmologic Surgery
Cirugía Oftalmológica

Information about the full text
Acerca del trabajo completo

Sequential Posterior Subtenon Injection of Triamcinolone Acetonide With Macular Grid/Focal Photocoagulation for Clinically Significant Diabetic Macular Edema

Author / Autor
Chung-May Yang¹, Yu-Shu Liu², Yun-Dun Shen³

3 Md, Department Of Ophthalmology, Taipei Medical University–shuang Ho Hospital, Taipei, Taiwan, Attending Physician

Access to the original source
Taiwan Journal of Ophthalmology

Article URL: / URL del artículo:
http://www.e-tjo.org
siic DB: / siic DB:
http://www.siicsalud.com/main/distriprinrel.php

ua32218

Acerca de SIIC

Authors' Reports

Acceso para suscriptores